English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52728269    線上人數 :  548
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu chih hung"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 166-175 / 175 (共7頁)
<< < 1 2 3 4 5 6 7 
每頁顯示[10|25|50]項目

機構 日期 題名 作者
國立臺灣大學 2002 High-Frequency Microsatellite Instability Predicts Better Chemosensitivity to High-Dose 5-Fluorouracil Plus Leucovorin Chemotherapy for Stage Iv Sporadic Colorectal Cancer after Palliative Bowel Resection 梁金銅; 黃國晉; 賴鴻緒; 許輝吉; 徐志宏; LIANG, JIN-TUNG; HUANG, KUO-CHIN; LAI, HONG-SHIEE; HSU, HEY-CHI; HSU, CHIH-HUNG
國立臺灣大學 2002 Induction of Epstein-Barr Rirus (Ebv) Reactivation in Raji Cells by Doxorubicin and Cisplatin 徐志宏; 鄭安理; HSU, CHIH-HUNG; CHENG, ANN-LII
國立臺灣大學 2002 Prognostic Value of Multidrug Resistance 1 (Mdr 1), Glutathione-S- Transferase P (Gst P), and P53 in Advanced Nasopharyngeal Carcinoma (Npc) Treated with Systemic Chemotherapy 徐志宏; 陳志榮; 洪瑞隆; 林靜芳; 鄭安理; HSU, CHIH-HUNG; CHEN, CHI-LONG; HONG, RUEY-LONG; LIN, JING-FANG; CHENG, ANN-LII
國立臺灣大學 2002 The Chemopreventive Compound Curcumin Is an Efficient Inhibitor of Epstein-Barr Virus Bzlf1 Transcription in Raji Dr-Luc Cells 徐志宏; 鄭安理; HSU, CHIH-HUNG; CHENG, ANN-LII
國立臺灣大學 2002 A Phase Ii Study of Weekly Methotrexate, Cisplatin, and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin (Mp-Hdfl) in Patients with Metastatic and Recurrent Esophageal Cancer-Improving Toxicity Profile by Infusional Schedule and Double Biochem 徐志宏; 鄭安理; 許駿; 楊志新; 盧彥伸; 卜慶芳; 葉坤輝; HSU, CHIH-HUNG; CHENG, ANN-LII; HSU, CHIUN; YANG, CHIH-HSIN; LU, YEN-SHEN; BU, CHING-FANG; YEH, KUN-HUEI
國立臺灣大學 2002 Combination of 13-Cis Retinoic Acid and Interferon-Alpha in the Treatment of Recurrent or Refractory Peripheral T-Cell Lymphoma 黃敬倫; 蘇益仁; 田蕙芬; 唐季祿; 葉坤輝; 王秋華; 徐志宏; 鄭安理; HUANG, CHING-LUN; SU, IH-JEN; TIEN, HWEI-FANG; TANG, JIH-LUH; YEH, KUN-HUEI; WANG, CHIU-HWA; HSU, CHIH-HUNG; CHENG, ANN-LII
國立臺灣大學 2001 Phase I Clinical Trial of Curcumin, a Chemopreventive Agent, in Patients with High-Risk or Pre-Malignant Lesions 鄭安理; 徐志宏; 林仁混; 徐茂銘; 沈宗憲; 何藴芳; 柯政郁; 林肇堂; 吳明賢; 紀秀華; CHENG, ANN-LII; HSU, CHIH-HUNG; LIN, JEN-KUN; HSU, MOW-MING; SHEEN, TZUNG-SHIAHN; HO, YUNN-FANG; KO, JENQ-YUH; LIN, JAW-TOWN; WU, MING-SHIANG; JEE, SHIOU-HWA
國立臺灣大學 2001 A Pilot Study of Afl-T (Doxorubicin, 5-Fluorouracil, Leucovorin, and Tamoxifen) Combination Chemotherapy for Hormone-Refractory Prostate Cancer 林家齊; 徐志宏; 陳淳; 蔡崇璋; 鄭安理; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; CHEN, JUN; TSAI, TSONG-CHANG; CHENG, ANN-LII; PU, YEONG-SHIAU
國立臺灣大學 2001 Combination Chemotherapy of Cisplatin, Methotrexate, Vinblastine, and High-Dose Tamoxifen for Transitional Cell Carcinoma 徐志宏; 陳淳; 鄭安理; 蒲永孝; HSU, CHIH-HUNG; CHEN, JUN; CHENG, ANN-LII; PU, YEONG-SHIAU
國立臺灣大學 2000 Curcumin-Containing Diet Inhibits Diethylnitrosamine-Induced Murine Hepatocarcinogenesis 莊雙恩; 郭明良; 徐志宏; 陳志榮; 林仁混; 賴基銘; 謝長堯; 鄭安理; CHUANG, SHUANG-EN; KUO, MIN-LIANG; HSU, CHIH-HUNG; CHEN, CHI-LONG; LIN, JEN-KUN; LAI, GI-MING; HSIEH, CHANG-YAO; CHENG, ANN-LII

顯示項目 166-175 / 175 (共7頁)
<< < 1 2 3 4 5 6 7 
每頁顯示[10|25|50]項目